Joshua A Roth - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Joshua A Roth

Showing results (41-50 of 52) with videos related to

Pageof 6

Sort By:

Chest|October 13, 2019

Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and MediastinoscopyFrancys C Verdial, Kathleen S Berfield, Douglas E Wood, et al.

Advances in Therapy|November 13, 2023

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation StudyJingyan Yang, Basit I Chaudhry, Andrew T Yue, et al.

Journal of Medical Economics|September 28, 2018

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United StatesJoshua A Roth, Sean D Sullivan, Vincent W Lin, et al.

MDM Policy & Practice|February 17, 2023

Translating an Economic Analysis into a Tool for Public Health Resource Allocation in Cancer SurvivorshipZachary Rivers, Joshua A Roth, Winona Wright, et al.

Transplantation and Cellular Therapy|May 4, 2025

Out-of-Pocket Expenditures and Financial Hardship Among Patients With Myelodysplastic Syndrome Undergoing Allogeneic Transplant or Hypomethylating Agent / Supportive Care (BMT CTN 1102)Christopher T Su, Wael Saber, Aasthaa Bansal, et al.

Future Oncology (London, England)|December 3, 2025

Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare populationJoshua A Roth, Paul G D'Amico, Joseph C Cappelleri, et al.

Menopause (New York, N.Y.)|March 6, 2020

The Women's Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groupsMacarius M Donneyong, Teng-Jen Chang, Joshua A Roth, et al.

Transplantation and Cellular Therapy|April 29, 2023

Cost-Effectiveness of Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Bone Marrow Transplantation: Evidence from BMT CTN 1101Scott D Ramsey, Aasthaa Bansal, Lily Li, et al.

Journal of Managed Care & Specialty Pharmacy|July 16, 2024

Stakeholder perspectives on the sustainability of the United States biosimilars marketSean D Sullivan, Sophia Z Humphreys, David Fox, et al.

Annals of Internal Medicine|May 7, 2014

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling studyJoshua A Roth, Ruth Etzioni, Teresa M Waters, et al.

Pageof 6

Search research articles

Showing results (41-50 of 52) with videos related to

Sort By:

Pageof 6

Chest|October 13, 2019

Safety and Costs of Endobronchial Ultrasound-Guided Nodal Aspiration and MediastinoscopyFrancys C Verdial, Kathleen S Berfield, Douglas E Wood, et al.

Advances in Therapy|November 13, 2023

Journal of Medical Economics|September 28, 2018

Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United StatesJoshua A Roth, Sean D Sullivan, Vincent W Lin, et al.

MDM Policy & Practice|February 17, 2023

Translating an Economic Analysis into a Tool for Public Health Resource Allocation in Cancer SurvivorshipZachary Rivers, Joshua A Roth, Winona Wright, et al.

Transplantation and Cellular Therapy|May 4, 2025

Future Oncology (London, England)|December 3, 2025

Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare populationJoshua A Roth, Paul G D'Amico, Joseph C Cappelleri, et al.

Menopause (New York, N.Y.)|March 6, 2020

The Women's Health Initiative Estrogen-alone Trial had differential disease and medical expenditure consequences across age groupsMacarius M Donneyong, Teng-Jen Chang, Joshua A Roth, et al.

Transplantation and Cellular Therapy|April 29, 2023

Journal of Managed Care & Specialty Pharmacy|July 16, 2024

Stakeholder perspectives on the sustainability of the United States biosimilars marketSean D Sullivan, Sophia Z Humphreys, David Fox, et al.

Annals of Internal Medicine|May 7, 2014

Economic return from the Women's Health Initiative estrogen plus progestin clinical trial: a modeling studyJoshua A Roth, Ruth Etzioni, Teresa M Waters, et al.

Pageof 6